Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
284 studies found for:    cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Iodine I 124;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography;   Drug: Trametinib
22 Recruiting Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Gastric Cardia Adenocarcinoma;   Stage IB Gastric Cancer;   Stage IIA Gastric Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Gastric Cancer
Interventions: Drug: Carboplatin;   Procedure: Computed Tomography;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin;   Drug: Paclitaxel;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery
23 Recruiting 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Conditions: Metastatic Malignant Neoplasm in the Brain;   Primary Brain Neoplasm;   Recurrent Brain Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fluorothymidine F-18;   Procedure: Positron Emission Tomography
24 Recruiting Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
Conditions: Ovarian Carcinoma;   Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Copper Cu 64-DOTA B-Fab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography
25 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Malignant Glioma;   Recurrent Brain Neoplasm
Interventions: Procedure: Biopsy;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Drug: Fluorine F 18 Fluorodopa;   Other: Laboratory Biomarker Analysis;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography;   Procedure: Therapeutic Conventional Surgery
26 Recruiting 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Condition: Prostate Neoplasm
Interventions: Device: CAT;   Radiation: Fluorine F 18 d-FMAU;   Other: Laboratory Biomarker Analysis;   Procedure: Multiparametric Magnetic Resonance Imaging;   Device: Positron Emission Tomography;   Device: Ultrasound
27 Recruiting Evaluation of Breast CT
Condition: Breast Cancer
Intervention: Radiation: computed tomography
28 Recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
29 Not yet recruiting Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Conditions: Child-Pugh Class A;   Child-Pugh Class B;   Recurrent Hepatocellular Carcinoma
Interventions: Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Stereotactic Body Radiation Therapy;   Procedure: Transarterial Chemoembolization;   Drug: Chemotherapy agent;   Drug: embolic agent;   Drug: lipiodol
30 Recruiting PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
Conditions: Metastatic Malignant Neoplasm in the Brain;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Procedure: Computed Tomography;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography;   Radiation: Proton Beam Radiation Therapy
31 Recruiting Myeloid Derived Suppressor Cells Clinical Assay in Finding and Monitoring Kidney Cancer
Conditions: Healthy Subject;   Metastatic Renal Cell Cancer;   Recurrent Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Procedure: Computed Tomography;   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging
32 Not yet recruiting Combination Therapy With Pembrolizumab and sEphB4-HSA in Previously Treated Urothelial Carcinoma
Condition: Stage IV Bladder Urothelial Carcinoma
Interventions: Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Biological: Recombinant EphB4-HSA Fusion Protein
33 Recruiting 18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: B-Cell Neoplasm;   Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Renal Cell Cancer;   Progesterone Receptor Negative;   Stage III Mesothelioma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Triple-Negative Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging
34 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Undifferentiated Carcinoma;   Recurrent Cervical Carcinoma;   Stage IB2 Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Procedure: Positron Emission Tomography
35 Recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: etoposide;   Drug: cyclophosphamide;   Radiation: total marrow irradiation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
36 Recruiting Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma;   Recurrent Laryngeal Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Recurrent Oral Cavity Squamous Cell Carcinoma;   Recurrent Oropharyngeal Squamous Cell Carcinoma;   Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage III Hypopharyngeal Squamous Cell Carcinoma;   Stage III Laryngeal Squamous Cell Carcinoma;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Hypopharyngeal Squamous Cell Carcinoma;   Stage IVA Laryngeal Squamous Cell Carcinoma;   Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Hypopharyngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Squamous Cell Carcinoma;   Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Hypopharyngeal Squamous Cell Carcinoma;   Stage IVC Laryngeal Squamous Cell Carcinoma;   Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Radiation: Stereotactic Body Radiation Therapy;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Quality-of-Life Assessment
37 Recruiting Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Conditions: Chronic Obstructive Pulmonary Disease;   HIV;   Emphysema
Interventions: Procedure: blood draw;   Procedure: questionnaires;   Procedure: Lung function testing;   Procedure: Six-Minute walk test;   Radiation: Quantitative CT scans;   Procedure: Nasal secretion and cell collection;   Procedure: Echocardiogram;   Procedure: Glycocalyx
38 Recruiting DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy
Conditions: Head and Neck Cancer;   Lung Cancer;   Prostate Cancer
Intervention: Device: CT Scan
39 Recruiting Electrical Impedance Imaging of Patients on Mechanical Ventilation
Conditions: Pneumothorax;   Pulmonary Contusion;   Pleural Effusion;   Pulmonary Edema;   Atelectasis;   Hyperinflation;   Emphysema;   Acute Respiratory Distress Syndrome
Interventions: Device: Mechanical Ventilation;   Device: CT Scan
40 Not yet recruiting Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli
Condition: Multiple Pulmonary Emboli
Interventions: Procedure: Low-Dose IV Contrast;   Device: Siemens Sensation 64-MDCT scanner.;   Drug: Visipaque 320 non-ionic isoosmolar contrast agent

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years